Macrolides use and the risk of sudden cardiac death

Expert Rev Anti Infect Ther. 2016 Jun;14(6):535-7. doi: 10.1080/14787210.2016.1179580. Epub 2016 May 3.

Authors

Xiang Li¹, Min Wang², Guiyang Liu¹, Liang Zhou¹, Zhe Wang¹, Chuntong Li¹

Affiliations

¹ a Department of Pharmacy , First Affiliated Hospital of Chinese PLA General Hospital , Beijing , China.
² b No. 263 Clinical Department , General Hospital of PLA Army , Beijing , China.

PMID: 27086751
DOI: 10.1080/14787210.2016.1179580

No abstract available

Keywords: Macrolides; arrhythmia; coronary heart disease; sudden cardiac death; torsades de pointes.

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / adverse effects*
Anti-Bacterial Agents / therapeutic use
Arrhythmias, Cardiac / chemically induced
Arrhythmias, Cardiac / epidemiology
Azithromycin / adverse effects
Azithromycin / therapeutic use
Clarithromycin / adverse effects
Clarithromycin / therapeutic use
Coronary Artery Disease / epidemiology
Coronary Disease / epidemiology
Death, Sudden, Cardiac / epidemiology*
Erythromycin / adverse effects
Erythromycin / therapeutic use
Humans
Macrolides / adverse effects*
Macrolides / therapeutic use
Plaque, Atherosclerotic / epidemiology
Risk Factors
Torsades de Pointes / chemically induced*
Torsades de Pointes / epidemiology

Substances

Anti-Bacterial Agents
Macrolides
Erythromycin
Azithromycin
Clarithromycin